Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cosmeceutical peptides.

Mary P Lupo1

  • 1Department of Dermatology, Tulane University School of Medicine, New Orleans, LA 70124, USA. MPLupoMD@aol.com

Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|July 21, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a Core Outcome Domain Set for Facial Aging.

JAMA dermatology·2026
Same author

Effect of Topical Human Platelet Extract (HPE) for Facial Skin Rejuvenation: A Histological Study of Collagen and Elastin.

Journal of drugs in dermatology : JDD·2024
Same author

Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis.

Dermatology and therapy·2024
Same author

Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.

Aesthetic surgery journal·2021
Same author

The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.

Aesthetic surgery journal·2021
Same author

Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II-induced cutaneous inflammation.

JAAD case reports·2021

Peptide cosmeceuticals show potential for improving aging skin appearance. For effectiveness, products need stability, skin absorption, and biological activity for clinical benefit.

Area of Science:

  • Dermatology
  • Cosmeceutical science
  • Skin aging research

Background:

  • Cosmeceuticals bridge cosmetics and drugs, aiming to improve skin appearance beyond camouflage.
  • Ingredients are often chosen based on in vitro studies of wound healing and metabolic processes.
  • Growing demand for anti-aging solutions drives cosmeceutical innovation.

Purpose of the Study:

  • To equip practicing dermatologists with information on cosmeceuticals.
  • To provide a scientific basis for patient consultations on skin improvement products.
  • To clarify the role of specific ingredients in cosmeceutical efficacy.

Main Methods:

  • Compilation of published research on topical peptides.
  • Review of studies on the effects and applications of peptides for skin.

Related Experiment Videos

  • Analysis of scientific literature regarding cosmeceutical ingredients.

    • Main Results:

    • Evidence suggests peptide cosmeceuticals can enhance the appearance of aging skin.
    • Product stability, skin absorption, and target biological activity are crucial for clinical benefits.
    • In vitro findings require translation to in vivo efficacy for tangible results.

    Conclusions:

    • This review offers dermatologists background knowledge on peptide cosmeceuticals.
    • Aims to empower clinicians to address patient questions about these products.
    • Highlights the scientific considerations for effective cosmeceutical use in dermatology.